| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 27-Dec-08 | | Total Revenue | 1,549,300 | 1,455,400 | 1,426,200 | 1,511,500 | | Cost of Revenue | 1,113,300 | 1,065,100 | 1,081,100 | 1,133,100 | | | Gross Profit | 436,000 | 390,300 | 345,100 | 378,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 323,100 | 202,800 | 401,500 | 309,800 | | Non Recurring | (126,900) | 126,900 | 832,000 | 7,800 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 239,800 | 60,600 | (888,400) | 60,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (162,400) |
-
|
-
| (4,500) | | Earnings Before Interest And Taxes | 77,400 | 60,600 | (888,400) | 56,300 | | Interest Expense | 19,100 | 20,400 | 27,500 | 28,100 | | Income Before Tax | 58,300 | 40,200 | (915,900) | 28,200 | | Income Tax Expense | (4,200) | 400 | (17,000) | (14,400) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 62,500 | 39,800 | (898,900) | 42,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 62,500 | 39,800 | (898,900) | 42,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $62,500 | $39,800 | ($898,900) | $42,600 |
|
1.52% Nasdaq 0.00%
Income Statement
